NEW YORK (GenomeWeb) – The French National Authority for Health (HAS) earlier this week published a public health recommendation that advises to make circulating cell-free DNA testing for fetal trisomy 21 in maternal blood available to all pregnant women if their first trimester combined screen indicates an increased risk.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.